According to immunohistochemical characteristics, breast cancer is clinically classified into four types including luminal A type, luminal B type, human epidermal growth factor receptor 2 (HER2) overexpression type, and triple-negative breast cancer (TNBC). Here, ERBB2 is linked to triple-negative breast carcinoma.